Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Bloomberg Markets

GSK in Talks to Buy Nuvalent for More Than $9 Billion: FT

GSK in Talks to Buy Nuvalent for More Than $9 Billion: FT
ShareXFacebook

GSK Plc is in discussions to purchase cancer treatment maker Nuvalent Inc. for between $9 billion and $10 billion, the Financial Times reported, citing unidentified people familiar with the matter.

B

Source

Bloomberg Markets

Read full article at Bloomberg Markets

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement